Filler Face-Off: sculptra vs radiesse at the genetic level

NCT ID NCT05620043

First seen Apr 24, 2026 · Last updated Jun 23, 2026 · Updated 17 times

Summary

This study looked at how two different dermal fillers—Sculptra and Radiesse Plus—change gene activity in the skin. Researchers took small skin samples from 21 people after treatment to measure genes related to collagen, elastin, and skin repair. The goal was to understand which filler might better support skin health at a molecular level.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GENE EXPRESSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Miami Dermatology & Laser Institute

    Miami, Florida, 33173, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Poly-L-lactic acid (Sculptra) and calcium hydroxylapatite (Radiesse Plus)

What this could lead to

If successful, this could help doctors choose which filler is better for stimulating collagen and skin repair based on genetic markers.

What could go wrong

This is a very small, early study (21 people) looking at gene changes, not actual cosmetic outcomes. Results may not predict real-world effectiveness or apply to everyone.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.